浙江医药

- 600216

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2022  2021  2020  2019  2018  2017  2016  2015  2014  2013  2012 
浙江医药(600216) 利润表
单位:万元
报表日期2022-03-312021-12-312021-09-302021-06-302021-03-31
一、营业总收入218,419.21912,909.45681,165.20461,754.41239,993.49
营业收入218,419.21912,909.45681,165.20461,754.41239,993.49
二、营业总成本188,401.42793,230.07596,686.20401,870.28211,058.50
营业成本135,851.33539,973.61397,712.13262,353.67141,594.17
营业税金及附加1,843.167,517.175,467.473,390.812,206.98
销售费用23,337.61112,941.6993,979.5461,585.5930,916.65
管理费用8,190.3342,800.7325,087.1216,132.918,831.54
财务费用1,879.209,310.985,175.193,872.111,909.32
研发费用17,299.7880,685.9069,264.7554,535.1925,599.85
资产减值损失----------
公允价值变动收益-2,602.825,172.645,537.321,416.59-46.20
投资收益1,708.944,181.464,393.651,806.06390.55
其中:对联营企业和合营企业的投资收益-178.34-423.98137.8782.8912.38
汇兑收益----------
三、营业利润26,801.77117,943.6787,104.6158,610.1530,802.61
加:营业外收入14.13103.9693.8777.93120.25
减:营业外支出266.282,694.471,746.741,131.32831.93
其中:非流动资产处置损失----------
四、利润总额26,549.62115,353.1685,451.7457,556.7730,090.94
减:所得税费用5,065.1726,897.5616,860.7410,662.885,371.11
五、净利润21,484.4488,455.6068,591.0146,893.8824,719.83
归属于母公司所有者的净利润26,054.32104,531.9975,061.4850,762.1126,686.87
少数股东损益-4,569.87-16,076.39-6,470.48-3,868.23-1,967.04
六、每股收益
基本每股收益(元/股)0.27001.09000.78000.53000.2800
稀释每股收益(元/股)0.27001.09000.78000.53000.2800
七、其他综合收益-410.10-1,553.04-886.91-587.16-412.44
八、综合收益总额21,074.3486,902.5767,704.1046,306.7324,307.39
归属于母公司所有者的综合收益总额25,676.35103,091.3374,241.9350,229.8626,308.32
归属于少数股东的综合收益总额-4,602.01-16,188.77-6,537.83-3,923.14-2,000.93
下载全部历史数据到excel中 返回页顶